Literature DB >> 9494849

A population based survey of hepatitis B virus infection in a southern Italian town.

T Stroffolini1, V Guadagnino, P Chionne, B Procopio, E G Mazzuca, F Quintieri, P Scerbo, A Giancotti, S Nisticò, A Focà, M E Tosti, M Rapicetta.   

Abstract

BACKGROUND: The level of endemicity and modes of transmission of hepatitis B virus infection may change over time. AIMS: To assess prevalence of and risk factors for hepatitis B infection in the general population.
SUBJECTS: A total of 1352 subjects residing in a Southern Italian town in the year 1996.
METHODS: Subjects were selected from the census by a systematic 1:4 random sampling procedure. Hepatitis B surface antigen and antibodies to hepatitis B core antigen were detected by ELISA. The association (Odds Ratio) linking hepatitis B seropositivity to potential risk factors was estimated by univariate and multivariate analysis.
RESULTS: The participation rate was 96.6%. The overall prevalence of hepatitis B surface antigen and antibodies to hepatitis B core antigen were 0.8% and 21.5%, respectively. Hepatitis B surface antigen prevalence was 0.2% in subjects younger than 30 years, peaked to 2.5% in the age-group 40-49 years, and decreased to 0.3% in those 60 years and older. Antibodies to hepatitis B core antigen positivity linearly increased from 6.2% in subjects < 30 years of age to 37.1% in those 60 years or older (p < 0.01). The results of multiple logistic regression analysis showed that age > 45 years (Odds Ratio = 1.9; Confidence Intervals 95% = 1.2-3.0), use of glass syringes (Odds Ratio = 2.2; Confidence Intervals 95% = 1.5-3.4), surgical intervention (Odds Ratios = 1.8; Confidence Intervals: 95% = 1.3-2.6), and positivity for antibodies to hepatitis C virus infection (Odds Ratios = 2.6; Confidence Intervals 95% = 1.5-4.3) were all independent predictors of the likelihood of hepatitis B positivity.
CONCLUSIONS: Given that a significant proportion of the general population undergoes surgical intervention, the association found between hepatitis B positivity and this exposure highlights the importance of further developing efficient procedures for the sterilization of instruments as well as the use of disposable materials to control the spread of infection.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9494849

Source DB:  PubMed          Journal:  Ital J Gastroenterol Hepatol        ISSN: 1125-8055


  6 in total

Review 1.  Hepatitis B and immunosuppressive therapies for chronic inflammatory diseases: When and how to apply prophylaxis, with a special focus on corticosteroid therapy.

Authors:  Pilar López-Serrano; Elsa de la Fuente Briongos; Elisa Carrera Alonso; Jose Lázaro Pérez-Calle; Conrado Fernández Rodríguez
Journal:  World J Hepatol       Date:  2015-03-27

2.  Prevalence of markers of hepatitis B virus infection or vaccination in HBsAg-negative subjects.

Authors:  Massimo De Paschale; Maria Teresa Manco; Luisa Belvisi; Bruno Brando; Stefania Latella; Carlo Agrappi; Paola Mirri; Arianna Gatti; Pierangelo Clerici
Journal:  Blood Transfus       Date:  2012-04-13       Impact factor: 3.443

3.  Long-term immunogenicity of hepatitis B vaccination in children and adolescents in a southern Italian town.

Authors:  T Stroffolini; V Guadagnino; B Caroleo; G De Sarro; A Focà; M C Liberto; A Giancotti; G S Barreca; N Marascio; F L Lombardo; O Staltari
Journal:  Infection       Date:  2011-12-16       Impact factor: 3.553

4.  Prevalence, risk factors and evaluation of a screening strategy for chronic hepatitis C and B virus infections in healthy company employees.

Authors:  V Sypsa; E Hadjipaschali; A Hatzakis
Journal:  Eur J Epidemiol       Date:  2001       Impact factor: 8.082

Review 5.  Hepatitis B and C virus reactivation in immunosuppressed patients with inflammatory bowel disease.

Authors:  Stefano Sansone; Maria Guarino; Fabiana Castiglione; Antonio Rispo; Francesco Auriemma; Ilaria Loperto; Matilde Rea; Nicola Caporaso; Filomena Morisco
Journal:  World J Gastroenterol       Date:  2014-04-07       Impact factor: 5.742

6.  An assessment of the effect of hepatitis B vaccine in decreasing the amount of hepatitis B disease in Italy.

Authors:  Giuseppe La Torre; Nicola Nicolotti; Chiara de Waure; Giacomina Chiaradia; Maria Lucia Specchia; Alice Mannocci; Walter Ricciardi
Journal:  Virol J       Date:  2008-07-24       Impact factor: 4.099

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.